← Back to Search

Behavioral Intervention

WeWomen Plus Intervention for Domestic Violence Survivors (IWWP Trial)

N/A
Recruiting
Led By Bushra Sabri
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-64 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 12 months
Awards & highlights

IWWP Trial Summary

This trial looks at how well a technology-based intervention called "weWomenPlus" helps abused immigrant women feel safe, mentally healthy, and empowered.

Who is the study for?
This trial is for foreign-born immigrant women aged 18-64 who have experienced intimate partner violence within the past year and can use internet and phone. It's not for those under 18 or over 64, US-born individuals, or those without recent intimate partner violence experience.Check my eligibility
What is being tested?
The study tests 'weWomenPlus,' an adaptive technology-based intervention delivered online, via text, and phone to see if it improves safety, mental health, and empowerment of abused immigrant women.See study design
What are the potential side effects?
Since this is a non-medical intervention focusing on support through technology (online resources, texting services), side effects are not typical as with drug trials but may include emotional distress due to discussing sensitive topics.

IWWP Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 64 years old.

IWWP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3 months, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in severity of physical violence as assessed by the revised Conflict Tactics Scale
Secondary outcome measures
Change in depressive symptoms as assessed by the Patient Health Questionnaire (PHQ-9)
Change in empowerment related to safety as assessed by the Measure of Victim Empowerment Related to Safety (MOVERS) scale
Change in overall empowerment as assessed by the Personal Progress Scale-Revised
+1 more

IWWP Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: WeWomen Plus Text messaging onlyExperimental Treatment1 Intervention
For second stage randomization, the text messaging intervention will follow-up with non-responder group of immigrant women (those who did not improve in intervention or control arms above) on their enactment of tailored (tailored to the DA Score and priorities) safety plan provided in the online weWomen intervention or non-tailored (standard list of resources) safety recommendations provided in the usual care control arm
Group II: WeWomen Plus Text messaging and phoneExperimental Treatment1 Intervention
Second stage randomization will involve both text (described above) and phone calls for non-responder group of women in intervention or control arm. The phone calls will draw from motivational interviewing adapted for abused women, solution focused therapy and a strengths perspective to discuss women's safety concerns and other needs, and strategies to strengthen social support networks
Group III: Online weWomen InterventionExperimental Treatment1 Intervention
For first stage randomization, women in the intervention group receive the online safety planning intervention informed by culturally specific danger assessment (DA) tool.
Group IV: Online usual care or no treatment controlActive Control1 Intervention
Women in the control group receive the non-DA informed usual safety planning resources modeled on national and state domestic violence online resources, but not provided with immediate and visual feedback to their level of danger or a tailored safety planning.

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,260 Previous Clinical Trials
14,819,514 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,214,945 Total Patients Enrolled
Bushra SabriPrincipal InvestigatorJohns Hopkins University

Media Library

WeWomen Plus (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT04098276 — N/A
Domestic Violence Research Study Groups: WeWomen Plus Text messaging only, Online weWomen Intervention, Online usual care or no treatment control, WeWomen Plus Text messaging and phone
Domestic Violence Clinical Trial 2023: WeWomen Plus Highlights & Side Effects. Trial Name: NCT04098276 — N/A
WeWomen Plus (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04098276 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the capacity of this trial for participants?

"Affirmative, clinicaltrials.gov data suggest that this investigation is currently enrolling participants. Having been first posted on the 11th of January 2021 and updated last on the 10th December 2021, it seeks to recruit 1,266 subjects from a single centre."

Answered by AI

Could I potentially participate in this scientific experiment?

"This study seeks to enrol 1,266 individuals aged 18-64 who have experienced domestic violence in the past year. Furthermore, participants must be foreign born immigrants that are able to use electronic communication devices and access the internet."

Answered by AI

Are applicants younger than sixty eligible for this experiment?

"To be considered for this clinical trial, individuals must fall within the 18-64 age range. Additionally, there exist 16 trials for those younger than 18 and 25 studies dedicated to elderly participants above 65 years old."

Answered by AI

Is the recruitment phase of this research endeavor still open?

"According to the data published on clinicaltrials.gov, this medical study is actively looking for participants and has been since 1/11/2021 with a most recent update on 12/10/2021."

Answered by AI
~215 spots leftby Dec 2024